Research Tracker›Biomarker Atlas›Marker Pages›High-Mobility Group Box 1 (HMGB1)

High-Mobility Group Box 1 (HMGB1): biomarker evidence

High-Mobility Group Box 1 (HMGB1) appears in 1 entry of the OSMF biomarker atlas, covering Epilepsy. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Epilepsy

Where High-Mobility Group Box 1 (HMGB1) is reported

ConditionDirectionCompared againstAssociated symptomsSource
Epilepsy↑ elevateddrug-responsive, well-controlled seizures and healthy controls—Walker et al. 2022

Frequently asked questions

In which conditions is High-Mobility Group Box 1 (HMGB1) altered?

In the OSMF atlas High-Mobility Group Box 1 (HMGB1) is reported in Epilepsy. It is elevated in 1 across 1 entries.

Is there a standard clinical test for High-Mobility Group Box 1 (HMGB1)?

The atlas entries for High-Mobility Group Box 1 (HMGB1) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal High-Mobility Group Box 1 (HMGB1) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). High-Mobility Group Box 1 (HMGB1) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/high-mobility-group-box-1-hmgb1.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.